| Literature DB >> 34066897 |
Suriya Rehman1, Munirah A Almessiere2, Ebtesam A Al-Suhaimi3, Mehwish Hussain4, Maha Yousuf Bari5, Syed Mehmood Ali6, Suhailah S Al-Jameel7, Yassine Slimani2, Firdos Alam Khan8, Abdulhadi Baykal9.
Abstract
In the present study, biocompatible manganese nanoparticles have been linked with zinc and iron molecules to prepare different derivatives of Mn0.5Zn0.5ErxYxFe2-2xO4 NPs (x = 0.02, 0.04, 0.06, 0.08, 0.10), using an ultrasonication approach. The structure, surface morphology, and chemical compositions of Mn0.5Zn0.5ErxYxFe2-2xO4 NPs were elucidated by X-ray diffractometer (XRD), High-resolution transmission electron microscopy (HR-TEM), scanning electron microscope (SEM), and Energy Dispersive X-Ray Analysis (EDX) techniques. The bioactivity of Mn0.5Zn0.5ErxYxFe2-2xO4 NPs on normal (HEK-293) and (HCT-116) colon cancer cell line was evaluated. The Mn0.5Zn0.5ErxYxFe2-2xO4 NPs treatment post 48 h resulted in a significant reduction in cells (via MTT assay, having an IC50 value between 0.88 µg/mL and 2.40 µg/mL). The specificity of Mn0.5Zn0.5ErxYxFe2-2xO4 NPs were studied by treating them on normal cells line (HEK-293). The results showed that Mn0.5Zn0.5ErxYxFe2-2xO4 NPs did not incur any effect on HEK-293, which suggests that Mn0.5Zn0.5ErxYxFe2-2xO4 NPs selectively targeted the colon cancerous cells. Using Candida albicans, antifungal activity was also studied by evaluating minimum inhibitory/fungicidal concentration (MIC/MFC) and the effect of nanomaterial on the germ tube formation, which exhibited that NPs significantly inhibited the growth and germ tube formation. The obtained results hold the potential to design nanoparticles that lead to efficient bioactivity.Entities:
Keywords: anti colon cancer activity; antifungal activity; biomedical; magnetic nanoparticles; ultrasonication
Year: 2021 PMID: 34066897 PMCID: PMC8150661 DOI: 10.3390/biom11050703
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1X-ray powder patterns of Mn0.5Zn0.5ErxYxFe2−2xO4 NPs (x = 0.02, 0.04, 0.06, 0.08, 0.10).
Figure 2FE-SEM images of Mn0.5Zn0.5ErxYxFe2−2xO4 NPs (x = 0.02, 0.04, 0.06, 0.08, 0.10).
Figure 3EDX and elemental mapping of Mn0.5Zn0.5ErxYxFe2−2xO4 NPs (x = 0.04).
Figure 4TEM images of Mn0.5Zn0.5ErxYxFe2−2xO4 NPs (x = 0.02, 0.04, 0.06, 0.08, 0.10) and histogram of particle size distribution.
Effect of Mn0.5Zn0.5ErxYxFe2−2xO4 NPs on cancerous cells (HCT-116) and normal cells (HEK-293).
| x | IC50 (HCT-116 | IC50 (HEK-293) |
|---|---|---|
| 0.02 | 0.88 µg/mL | No inhibition |
| 0.04 | 2.40 µg/mL | No inhibition |
| 0.06 | 0.85 µg/mL | No inhibition |
| 0.08 | 0.78 µg/mL | No inhibition |
| 0.10 | 0.45 µg/mL | No inhibition |
IC50 Value [µg/mL] = Inhibitory concentration (IC).
Figure 5DAPI-stained cancer cell morphology. HCT-116 cells treated with ultrasonicated Mn0.5Zn0.5ErxYxFe2−2xO4 NPs (x = 0.02, 0.10) for 48 h. (A) shows the untreated cells (control); (B) shows NPs treatment x = 0.02 concentration 0.88 µg/mL; and (C) shows treatment with x = 0.10 concentration (0.45 µg/mL). Arrows in (B,C) show the nuclear disintegration. 200× magnifications.
Figure 6MIC and MFC of ultrasonicated Mn0.5Zn0.5ErxYxFe2−2xO4 NPs against C. albicans survival.
Figure 7Inhibition in germ tube formation of treated C. albicans; (A) depicts the inhibition in percentage; (B) light microscopic images at 40× (a) control (untreated cells); (b) x = 0.02; (c) x = 0.04; (d) x = 0.06; (e) x = 0.08 and (f) x = 0.10 ultrasonicated Mn0.5Zn0.5ErxYxFe2−2xO4 NPs.